Provenance Initiatives Fund at the Center for NeuroGenetics
Fund Purpose
Develop a world class translational "Bench to Bedside" care delivery system of innovative therapeutics treatments for ALS. We will focus on the most common pathology and the most common genetics cause. Project 1 - Project 1a ALS Gene Discovery - Objectives: to identify novel expansion mutations that cause ALS in patients with unknown forms of ALS. Project 1 - Project 1b Cell Line Development and Characterization - Objectives: to generate patient derived lymphoblastoid (LCL) and induced pluripotent stem (iPS) cell lines from patients with unknown forms of ALS.
Develop a world class translational "Bench to Bedside" care delivery system of innovative therapeutics treatments for ALS. We will focus on the most common pathology and the most common genetics cause. Project 1 - Project 1a ALS Gene Discovery - Objectives: to identify novel expansion mutations that cause ALS in patients with unknown forms of ALS. Project 1 - Project 1b Cell Line Development and Characterization - Objectives: to generate patient derived lymphoblastoid (LCL) and induced pluripotent stem (iPS) cell lines from patients with unknown forms of ALS.
Give Now to this Fund
Other College of Medicine - Gainesville Giving Opportunities
Giving Opportunity
Advanced Therapeutic Endoscopy Fund
Giving Opportunity
William G. Lassiter, Jr. and Aneice R. Lassiter Pediatric Diabetes Research Fund
Giving Opportunity
Thomas P. Mitchell Professorship in Clinical Physics Fund